Employment Screening Platform HireRight Prices US$422 Million IPO

Pre-employment background screening firm HireRight (NYSE: HRT) started publicly trading on the New York Stock Exchange today. The firm’s initial public offering is looking to raise US$422.22 million.

The offering will be conducted through the issuance of 22.22 million common shares selling at US$19.00 per share.

The company granted the underwriters a 30-day over-allotment option to purchase additional 3.33 million common shares at the same IPO price. Credit Suisse and Goldman Sachs & Co. are all acting as lead bookrunners for the said offering.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

The firm also relayed that it intends to use the offering proceeds on repaying indebtedness, unwinding certain interest rate swaps, and for general corporate purposes, including continued investment in operating systems and technologies.

The offering is expected to close on November 2, 2021, subject to customary closing conditions.

The platform provides background screening services for potential job candidates for more than 40,000 customers across the globe. The firm said that it has screened over 20 million job applicants, employees, and contractors for its customers in 2020.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Questcorp Begins 600 Metre Phase 2B Drill Program at La Union

Selkirk Copper Wraps 54,579 Metre Phase 2 Program at Minto, Hits 5.97% Copper Equivalent

Related News

Viral Diseases Tester Virax Biolabs Prices Upsized US$6.75 Million IPO

Biopharmaceutical company Virax Biolabs Group Limited recently increased its initial public offering size as it...

Wednesday, June 22, 2022, 02:14:00 PM

SpaceX’s Prospectus Is Coming—and the Hype Is Already Ahead of the Numbers

SpaceX is about to file its public prospectus — the first time the world will...

Monday, May 18, 2026, 05:42:52 AM

Biotech Firm CinCor Pharma Kicks Off Nasdaq IPO Roadshow

Clinical-stage biopharmaceutical company CinCor Pharma, Inc. is setting its sights on trading at the Nasdaq...

Tuesday, January 4, 2022, 02:36:00 PM

LegalZoom Eyes Raising US$535.4 Million On Its Nasdaq IPO

Online legal platform LegalZoom.com Inc. announced Tuesday the pricing of its scheduled initial public offering...

Wednesday, June 30, 2021, 10:14:00 AM

Did Nasdaq Rewrite Its Index Rules for SpaceX?

Nasdaq adopted a sweeping overhaul of its Nasdaq-100 methodology in March 2026, effective May 1...

Monday, June 1, 2026, 05:43:36 AM